Breast cancer among nurses: Is the intensity of night work related to hormone receptor status?

American Journal of Epidemiology

Volumn 178, Issue 1, 2013, Pages 110-117

  Lie, Jenny Anne S ^a   Kjuus, Helge ^a   Zienolddiny, Shan ^a   Haugen, Aage ^a   Kjærheim, Kristina ^b  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b Cancer Registry of Norway ^*  (Norway)

Author keywords

breast cancer; case control studies; chronobiology phenomenon; estrogen; Norway; nurses; progesterone; receptors

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

CANCER; CHRONOLOGY; ESTROGENIC COMPOUND; HORMONE; REGRESSION ANALYSIS; RISK FACTOR; TUMOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPOSURE VARIABLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NIGHT WORK; NURSE; POSTMENOPAUSE;

BREAST CANCER; CASE-CONTROL STUDIES; CHRONOBIOLOGY PHENOMENON; ESTROGEN; NORWAY; NURSES; PROGESTERONE; RECEPTORS;

ADULT; AGED; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MIDDLE AGED; NORWAY; NURSES; ODDS RATIO; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REGISTRIES; RISK FACTORS; WORK SCHEDULE TOLERANCE;

NORWAY;

EID: 84880221526     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws428     Document Type: Article

References (35)

1. Straif K, Baan R, Grosse Y, et al. Carcinogenicity of shiftwork, painting, and fire-fighting. Lancet Oncol. 2007;8(12): 1065-1066
2. Tynes T, Hannevik M, Andersen A, et al. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control. 1996;7(2):197-204
3. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst. 2001;93(20): 1563-1568
4. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst. 2001; 93(20):1557-1562
5. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology. 2001;12(1): 74-77
6. O'Leary ES, Schoenfeld ER, Stevens RG, et al. Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol. 2006;164(4):358-366
7. Lie JA, Roessink J, Kjaerheim K. Breast cancer and night work among Norwegian nurses. Cancer Causes Control. 2006;17(1):39-44
8. Schernhammer ES, Kroenke CH, Laden F, et al. Night work and risk of breast cancer. Epidemiology. 2006;17(1):108-111
9. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007;33(5):336-343
10. Pesch B, Harth V, Rabstein S, et al. Night work and breast cancer-results from the German GENICA study. Scand J Work Environ Health. 2010;36(2):134-141
11. Pronk A, Ji BT, Shu XO, et al. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol. 2010;171(9):953-959
12. Lie JA, Kjuus H, Zienolddiny S, et al. Night work and breast cancer risk among Norwegian nurses: Assessment by different exposure metrics. Am J Epidemiol. 2011;173(11):1272-1279
13. Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems. Eur J Cancer. 2012;48(11):1722-1729
14. Hansen J, Lassen CF. Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med. 2012;69(8):551-556
15. Stevens RG. Electric power use and breast cancer: A hypothesis. Am J Epidemiol. 1987;125(4):556-561
16. Potter JD, Cerhan JR, Sellers TA, et al. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev. 1995;4(4):319-326
17. Colditz GA, Rosner BA, Chen WY, et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96(3):218-228
18. Chu KC, Anderson WF. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat. 2002;74(3): 199-211
19. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009; 45(7):1218-1231
20. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886
21. Costa G, Haus E, Stevens R. Shift work and cancer- considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 2010;36(2):163-179
22. Danforth DN Jr, Tamarkin L, Mulvihill JJ, et al. Plasma melatonin and the hormone-Dependency of human breast cancer. J Clin Oncol. 1985;3(7):941-948
23. Fritschi L, Glass DC, Heyworth JS, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 2011;77(3):430-436
24. Lange CA, Sartorius CA, Abdel-Hafiz H, et al. Progesterone receptor action: Translating studies in breast cancer models to clinical insights. Adv Exp Med Biol. 2008;630:94-111
25. Lydon JP, Ge G, Kittrell FS, et al. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999;59(17):4276-4284
26. Feinleib M. Breast cancer and artificial menopause: A cohort study. J Natl Cancer Inst. 1968;41(2):315-329
27. Trichopoulos D, MacMahon B, Cole P. Menopause and breast cancer risk. J Natl Cancer Inst. 1972;48(3):605-613
28. Beral V, Reeves G, Bull D, et al. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst. 2011;103(4):296-305
29. Chlebowski RT, Anderson GL, Gass M, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA. 2010;304(15):1684-1692
30. Groshong SD, Owen GI, Grimison B, et al. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-Dependent kinase inhibitors, p21 and p27(Kip1). Mol Endocrinol. 1997;11(11):1593-1607
31. Hurd C, Khattree N, Alban P, et al. Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. J Biol Chem. 1995;270(48): 28507-28510
32. Langley AR, Graham CH, Grundy AL, et al. A cross-sectional study of breast cancer biomarkers among shift working nurses. BMJ Open. 2012;2(1):e000532
33. Spitale A, Mazzola P, Soldini D, et al. Breast cancer classification according to immunohistochemical markers: Clinicopathologic features and short-Term survival analysis in a population-based study from the South of Switzerland. Ann Oncol. 2009;20(4):628-635
34. Parise CA, Bauer KR, Brown MM, et al. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004. Breast J. 2009;15(6): 593-602
35. Caldarella A, Crocetti E, Bianchi S, et al. Female breast cancer status according to ER, PR and HER2 expression: A population based analysis. Pathol Oncol Res. 2011;17(3): 753-758